Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better COVID Stock: Moderna vs. Pfizer

TheMotleyFool

0 0

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were the first to win U.S. Emergency Use Authorization (EUA) for their respective COVID-19 vaccines. This success has made Moderna a huge winner for shareholders, with the stock skyrocketing more than 570% over the last 12 months. It's been a different story for Pfizer, though, with the big drugmaker's shares rising only around 15% during the same period -- well below the return of the S&P 500 index.

But which of these two COVID-focused stocks is the better pick now? Here's how Pfizer and Moderna stack up against each other.

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share